Page 66 - TBE_Book_V2_2019

Chapter 2b: The molecular and antigenic structure of TBEV

104. Demina TV, Dzhioev YP, Verkhozina MM, 113. Tsouchnikas G, Zlatkovic J, Jarmer J, Strauss J,
Kozlova IV, Tkachev SE, Plyusnin A, et al. Vratskikh O, Kundi M, et al. Immunization with
Genotyping and characterization of the immune complexes modulates the fine
geographical distribution of tick-borne specificity of antibody responses to a flavivirus
encephalitis virus variants with a set of antigen. J Virol. 2015;89(15):7970-8.
molecular probes. J Med Virol. 2010;82(6):965-
76. 114. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A
structural perspective of the flavivirus life cycle.
105. Chernokhaeva LL, Rogova YV, Vorovitch MF, Nat Rev Microbiol. 2005;3(1):13-22.
Romanova LI, Kozlovskaya LI, Maikova GB, et al.
Protective immunity spectrum induced by 115. Kaufmann B, Rossmann MG. Molecular
immunization with a vaccine from the TBEV mechanisms involved in the early steps of
strain Sofjin. Vaccine. 2016;34(20):2354-61. flavivirus cell entry. Microb Infect. 2011;13(1):1-
9.
106. Kovalev SY, Mukhacheva TA. Tick-borne
116. Pierson TC, Diamond MS. Degrees of maturity:
encephalitis virus subtypes emerged through
rapid vector switches rather than gradual the complex structure and biology of
flaviviruses. Curr Opin Virol. 2012;2(2):168-75.
evolution. Ecol Evol. 2014;4(22):4307-16.
117. Dowd KA, Pierson TC. The many faces of a
107. Orlinger KK, Hofmeister Y, Fritz R, Holzer GW,
dynamic virion: implications of viral breathing
Falkner FG, Unger B, et al. A Tick-borne
on flavivirus biology and immunogenicity. Annu
Encephalitis Virus Vaccine Based on the
Rev Virol. 2018;5(1):185-207.
European Prototype Strain Induces Broadly
Reactive Cross-neutralizing Antibodies in 118. Dowd KA, Mukherjee S, Kuhn RJ, Pierson TC.
Humans. J Infect Dis. 2011;203(11):1556-64. Combined effects of the structural
heterogeneity and dynamics of flaviviruses on
108. Fritz R, Orlinger KK, Hofmeister Y, Janecki K,
antibody recognition. J Virol. 2014;88(20):11726
Traweger A, Perez-Burgos L, et al. Quantitative
-37.
comparison of the cross-protection induced by
tick-borne encephalitis virus vaccines based on 119. Pettersen EF, Goddard TD, Huang CC, Couch GS,
European and Far Eastern virus subtypes. Greenblatt DM, Meng EC, et al. UCSF Chimera--
Vaccine. 2012;30(6):1165-9. a visualization system for exploratory research
and analysis. J Comput Chem. 2004;25(13):1605
109. Dowd KA, DeMaso CR, Pierson TC. Genotypic
-12.
Differences in Dengue Virus Neutralization Are
Explained by a Single Amino Acid Mutation That
Modulates Virus Breathing. MBio. 2015;6
(6):e01559-15.
110. Goo L, VanBlargan LA, Dowd KA, Diamond MS,
Pierson TC. A single mutation in the envelope
protein modulates flavivirus antigenicity,
stability, and pathogenesis. PLoS pathogens.
2017;13(2):e1006178.
111. Beck Y, Fritz R, Orlinger K, Kiermayr S, Ilk R,
Portsmouth D, et al. Molecular Basis of the
Divergent Immunogenicity of Two Pediatric Tick
-Borne Encephalitis Virus Vaccines. J Virol
2016;90(4):1964-72.
112. Jarmer J, Zlatkovic J, Tsouchnikas G, Vratskikh O,
Strauss J, Aberle JH, et al. Variation of the
specificity of the human antibody responses
after tick-borne encephalitis virus infection and
vaccination. J Virol. 2014;88(23):13845-57.

61